Cost-effectiveness of treatment and care of patients with gastrointestinal inflammatory diseases: a systematic review - PubMed
3 hours ago
- #cost-effectiveness
- #inflammatory bowel disease
- #biologic therapy
- Systematic review on cost-effectiveness of biologic vs. non-biologic treatments for inflammatory bowel disease (IBD).
- Biologic therapies show superior health outcomes but higher costs, generally deemed cost-effective.
- Infliximab identified as cost-effective for Crohn’s disease; findings for ulcerative colitis varied.
- Surgical intervention (colectomy) cost-effective in specific clinical scenarios.
- Substantial methodological heterogeneity noted; future studies need consistency and transparency.